SCHEMBL21362759

SCHEMBL21362759

Cc1ccc(C(O)c2ccc(F)cc2O)c(Br)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
TRPA1 O75762 2/20 0.43
CHRM1 P11229 1/20 0.43
SLC6A2 P23975 1/20 0.43
ADRA1A P35348 1/20 0.43
HTR2B P41595 1/20 0.43
CA3 P07451 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
SRC P12931 1/20 0.33
KCNMA1 Q12791 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HSP90AA1 P07900 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157925 0.83 ALDH1A1 (0.36) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21362648 0.81 ACHE (0.39) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21352139 0.81 MAPT (0.40) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL21550045 0.81 DPP4 (0.35) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21362647 0.81 F2RL1 (0.40) LMNASLC6A2NPC1RAB9AL3MBTL1
SCHEMBL21550255 0.76 TRPA1 (0.33) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21550077 0.75 TRPA1 (0.33) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21564876 0.74 LMNA (0.34) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21549993 0.73 OPRM1 (0.38) NPC1RAB9AMAPTHTTGAA
SCHEMBL21550051 0.72 ALDH1A1 (0.38) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed